Abstract
Cancer-associated cachexia is a syndrome characterized by muscle mass and adipose tissue loss, which affects approximately 80% of advanced cancer patients. Circulating plasma mediators, called cachexia-mediating factors, have been implicated in the pathogenesis of the syndrome. These factors have a specific expression profile for each tumor type, and are associated with cachexia prevalenc…